# 医院和养老院益生菌市场

> 医院和护理院益生菌市场研究报告，按益生菌配方类型（胶囊、粉末、液体、软糖、益生菌酸奶）、按目标患者群体（婴儿、成人、老年人、免疫受损患者、肠胃疾病患者）、按适应症（抗生素相关性腹泻、肠易激综合症、艰难梭菌感染、炎症性肠病、一般肠道健康）、按分销渠道（医院、护理院、药店、在线零售、医疗设施）、按产品来源（细菌菌株、酵母菌株、共生菌、发酵食品）以及按地区（北美、欧洲、南美、亚太、中东和非洲） - 预测至2035年。

- **Forecast Period:** 2025 - 2035
- **CAGR:** 8.52%
- **2024:** $ 2.94 Billion
- **2025:** $ 3.19 Billion
- **2035:** $ 7.23 Billion
- **Key Players:** Danone (FR), Nestle (CH), Procter & Gamble (US), Kerry Group (IE), Chr. Hansen (DK), Lactalis Ingredients (FR), Synlogic (US), BioCare Copenhagen (DK), ProbioFerm (DE)

**Report ID:** MRFR/FnB/30179-HCR · **Pages:** 128 · **Author:** Varsha More · **Last Updated:** May 15, 2026

**URL:** https://www.marketresearchfuture.com/reports/hospital-and-nursing-home-probiotic-market-31965

---

## Market Summary

## **Global Hospital and Nursing Home Probiotic Market Overview**

Hospital and Nursing Home Probiotic Market Size was estimated at 2.3 (USD Billion) in 2022.The Hospital and Nursing Home Probiotic Industry is expected to grow from 2.49(USD Billion) in 2023 to 5.2 (USD Billion) by 2032. The Hospital and Nursing Home Probiotic Market CAGR (growth rate) is expected to be around 8.5% during the forecast period (2024 - 2032).

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Key Hospital And Nursing Home Probiotic Market Trends Highlighted**

The Hospital and Nursing Home Probiotic Market is witnessing significant growth driven by the rising awareness about the benefits of probiotics in enhancing the immune system and improving gut health among patients. Increased focus on infection control in healthcare settings is pushing hospitals and nursing homes to incorporate probiotics into their treatment protocols. The aging population, who are more susceptible to infections and other health issues, is another driver, amplifying the demand for natural and preventive health solutions.

Along with this, the proliferation of clinical studies showcasing the efficacy of probiotics in managing various health conditions is further underpinning market growth.

Opportunities in the market are abundant as healthcare providers look for holistic approaches to patient care. There is potential for developing advanced probiotic formulations tailored for specific patient groups, such as those undergoing surgery or dealing with chronic diseases. The exploration of probiotic applications in mental health and other emerging areas presents a unique avenue for growth. Additionally, the increasing trend of personalized medicine could lead to a surge in demand for customized probiotic therapies catering to individual patient needs. Recent trends indicate a growing incorporation of [probiotics](../../../reports/probiotics-market-966) into everyday healthcare practices, such as preventive measures against hospital-acquired infections.

Education and training of healthcare staff about the use of probiotics will likely become more prevalent, enabling better patient adherence to probiotic therapies. Furthermore, advancements in biotechnology are paving the way for innovative probiotic products that can provide targeted health benefits. As the understanding of gut-brain interactions continues to evolve, probiotics are expected to play a key role in fostering mental and physical well-being, particularly in hospital and nursing home settings. The shift towards preventive care and overall wellness emphasizes the need for integrating probiotics as an essential component of healthcare.

## **Hospital and Nursing Home Probiotic Market Drivers**

### **Increasing Awareness of Gut Health and Microbiome**

The rise in awareness regarding the importance of gut health and its direct impact on overall well-being has significantly driven the Hospital and Nursing Home Probiotic Market Industry. As healthcare professionals and patients alike recognize the role of a balanced microbiome in disease prevention and management, the demand for probiotics within healthcare settings has surged. The healthcare community is increasingly educating patients about the benefits of probiotics in mitigating the effects of antibiotic treatments, which can disrupt the natural flora in the gut.

This proactive approach towards maintaining a healthy gut through probiotic use is particularly crucial for patients recovering from illness or surgery, where a robust immune system is vital. Moreover, probiotics are being integrated into treatment protocols, with physicians recommending specific strains tailored to individual patient needs in both hospitals and nursing homes. This trend is expected to propel the growth of the market as more healthcare institutions adopt probiotics as part of their standard care practices, aiming to improve patient outcomes and reduce healthcare costs.

In addition, ongoing research continues to uncover new applications and potential benefits of probiotics, further boosting interest in the Hospital and Nursing Home Probiotic Market Industry. The exploration of probiotics in managing chronic diseases, gastrointestinal disorders, and post-surgical recovery highlights their evolving role in modern medicine. As patients become more informed and proactive about their health, it will lead to an increase in the prescribed and consumed probiotics in healthcare settings, ultimately shaping future market dynamics.

### **Aging Population and Rising Chronic Diseases**

The increasing aging population worldwide, coupled with a rise in chronic diseases, serves as a pivotal driver for the Hospital and Nursing Home Probiotic Market Industry. As older adults often face multiple health challenges, including weakened immune systems and digestive issues, probiotics are being recognized for their potential benefits in managing these conditions. This demographic shift necessitates innovative healthcare solutions, and probiotics have emerged as a viable option to enhance health outcomes among elderly patients.

With a growing emphasis on personalized healthcare, healthcare providers are keen to incorporate probiotics into treatment regimens tailored to the unique needs of older individuals, increasing their overall acceptability within hospital and nursing home settings.

### **Advancements in Probiotic Research and Product Development**

Continued advancements in probiotic research and the development of new products are significantly influencing the growth of the Hospital and Nursing Home Probiotic Market Industry. Researchers are exploring various strains of probiotics and their specific health benefits, leading to a broader range of effective options available to healthcare providers. Furthermore, innovations in delivery methods and formulations are enhancing the practical application of probiotics in clinical settings, paving the way for more positive outcomes.

As the availability of high-quality, effective probiotic products increases, healthcare facilities are more likely to adopt these solutions, contributing to the market's expansion.

## **Hospital and Nursing Home Probiotic Market Segment Insights**

### **Hospital and Nursing Home Probiotic Market Probiotic Formulation Type Insights**

The Hospital and Nursing Home Probiotic Market focuses significantly on the Probiotic Formulation Type segment, showcasing a diverse range of formulations that cater to various patient needs. In 2023, the market is valued at 2.49 USD Billion and is projected to reach 5.2 USD Billion by 2032, representing strong growth potential. The Probiotic Formulation Type encompasses five primary categories, namely Capsules, Powder, Liquid, Soft Chew, and Probiotic Yogurt, each contributing variably to the overall market landscape.

Among these, the Capsules formulation dominates, valued at 0.85 USD Billion in 2023 and anticipated to grow to 1.8 USD Billion by 2032, indicating its popularity due to ease of consumption and convenience for patients, particularly those in a hospital or nursing home setting.

The Powder formulation follows closely, holding a value of 0.65 USD Billion in 2023 and expected to reach 1.4 USD Billion by 2032, signifying its application in a variety of therapeutic solutions, particularly in the pediatric and senior care sectors where it can be easily incorporated into food and drinks. The Liquid formulation also plays a crucial role, starting at 0.55 USD Billion in 2023 and projected to rise to 1.2 USD Billion by 2032, appealing to patients who prefer or require liquid intake methods for easier digestion.

On the other hand, Soft Chew products are valued at 0.25 USD Billion in 2023, with prospects to reach 0.5 USD Billion by 2032, catering to a unique demographic that values palatability and ease of intake, often favored in geriatric care.

Lastly, Probiotic Yogurt stands at a value of 0.19 USD Billion in 2023, increasing to 0.3 USD Billion by 2032; while it represents a smaller market share, it offers an enjoyable means for patients to incorporate probiotics into their diet, thus fostering better adherence to probiotic intake recommendations. Each formulation type serves distinct patient preferences and dietary needs within hospitals and nursing homes, influencing the Hospital and Nursing Home Probiotic Market revenue and illustrating the importance of tailored therapeutic solutions.

The market trends depict a growing recognition of probiotics' health benefits, and as healthcare professionals increasingly endorse these formulations, it paves the way for new product developments and marketing strategies aimed at enhancing patient compliance and overall health outcomes.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Hospital and Nursing Home Probiotic Market Target Patient Group Insights**

The Hospital and Nursing Home Probiotic Market, valued at 2.49 USD Billion in 2023, has shown notable segmentation focused on various target patient groups. Each group plays a pivotal role in driving market development, with a focus on Infants and Elderly populations, who often face unique health challenges that probiotics can address, such as enhancing gut health and boosting immunity. Notably, the Adults segment also exhibits substantial demand, attributed to an increasing trend toward preventive healthcare. Immunocompromised Patients depend heavily on probiotics for maintaining gut balance and overall health, highlighting their critical importance in clinical settings.

Patients with Gastrointestinal Disorders represent a significant portion of the market, as these individuals often seek probiotics to alleviate symptoms and promote healing. The Hospital and Nursing Home Probiotic Market statistics suggest that the market will continue to evolve, driven by factors like an aging population and rising health awareness. While opportunities for growth remain prevalent, challenges such as regulatory scrutiny and the need for robust clinical evidence are present in the industry landscape. Overall, the ample potential within the target patient groups indicates a favorable outlook for the continued expansion of probiotic applications in healthcare settings.

### **Hospital and Nursing Home Probiotic Market Indication Insights**

In 2023, the Hospital and Nursing Home Probiotic Market was valued at 2.49 USD Billion, demonstrating a growing recognition of probiotics' importance in clinical settings. The Indication segment showcases diverse areas, such as Antibiotic-Associated Diarrhea, where the demand for probiotics is significant due to the common occurrence of treatment-related digestive issues. Irritable Bowel Syndrome is another critical area where probiotics have shown promising effects, leading to increased patient interest and usage. Clostridium difficile Infection, known for posing severe health risks, has heightened the focus on therapeutic probiotics as preventive and supportive measures.

Inflammatory Bowel Disease contributes to the rising need for specialized probiotic formulations, catering to affected patients seeking relief. General Gut Health also drives market demand, as individuals and healthcare providers are increasingly aware of the benefits probiotics provide beyond specific conditions. The overall growth is fueled by factors like the increasing prevalence of gastrointestinal disorders, the growing aging population, and rising awareness of maintaining gut health, highlighting the necessity of exploring various indications within the Hospital and Nursing Home Probiotic Market.

### **Hospital and Nursing Home Probiotic Market Distribution Channel Insights**

The Hospital and Nursing Home Probiotic Market revenue is witnessing substantial growth, with a valuation of 2.49 USD Billion in 2023. This growth can be largely attributed to the diverse distribution channels that play a pivotal role in market expansion. Among these channels, Hospitals and Nursing Homes are significant contributors, as they serve as primary nodes for probiotic administration and are critical for patient care. Pharmacies also characterize a vital segment, providing convenient access to probiotic products for consumers seeking health benefits.

Online retail is emerging as a dominant distribution channel due to the rising trend of e-commerce, emphasizing consumer preference for purchasing health products from the comfort of their homes. Additionally, Healthcare Facilities facilitate the direct supply of probiotics, enabling professional recommendations that bolster consumer trust. The increasing awareness of probiotics' health benefits, coupled with a growing geriatric population, supports the overall growth of this sector. However, challenges such as regulatory hurdles and competition from traditional medications persist.

Nonetheless, opportunities for innovation in product delivery and consumer education continue to shape the landscape of the Hospital and Nursing Home Probiotic Market industry.

### **Hospital and Nursing Home Probiotic Market Product Source Insights**

The Hospital and Nursing Home Probiotic Market is currently valued at 2.49 billion USD in 2023 and is poised for significant expansion. Within the Product Source segment, major categories include Bacterial Strains, Yeast Strains, Synbiotics, and Fermented Foods. Bacterial Strains hold a majority share in market revenue due to their extensive application in healthcare settings, as they effectively address various gastrointestinal issues and promote overall well-being. Yeast Strains are also important, as they contribute to enhancing patients' immune responses and gut health.

Additionally, Synbiotics, which combine prebiotics and probiotics, are gaining traction for their ability to synergistically improve health outcomes. Lastly, Fermented Foods appeal to a growing consumer preference for natural and functional food options. The market growth in this segment is driven by increasing awareness of probiotic benefits and rising demand in hospitals and nursing homes for effective solutions to improve patient health and recovery. The insights reflect a trend towards more personalized and holistic approaches in healthcare settings, further influencing overall market dynamics.

**Hospital and Nursing Home Probiotic Market Regional Insights**

The Hospital and Nursing Home Probiotic Market is experiencing significant growth across various regions, with a total valuation reaching 2.49 USD Billion in 2023 and projected to expand further. North America holds a significant position in this market, valued at 0.99 USD Billion in 2023, reflecting its majority holding due to advanced healthcare systems and increasing awareness of probiotics in hospitals. Europe follows closely with a valuation of 0.79 USD Billion, driven by strong regulatory support and growing adoption of probiotics in nursing homes.

Meanwhile, Asia Pacific represents a promising market with a valuation of 0.62 USD Billion in 2023, attributed to a rising aging population and increased healthcare expenditures. The Middle East and Africa region shows minimal value at 0.05 USD Billion, indicating a nascent stage in market development, while South America, valued at 0.05 USD Billion, presents opportunities for growth but faces challenges due to limited healthcare infrastructures. Each of these regional insights underscores the dynamic landscape of the Hospital and Nursing Home Probiotic Market and highlights potential areas for investment and expansion.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Hospital And Nursing Home Probiotic Market Key Players And Competitive Insights**

The Hospital and Nursing Home Probiotic Market is characterized by a dynamic landscape, where numerous players compete to establish their presence in this niche yet growing sector. As healthcare facilities increasingly recognize the importance of probiotics in enhancing patient outcomes, the market has witnessed a surge in interest and investment. Probiotics are known for their significant role in supporting gut health, which is particularly crucial in hospital and nursing home settings, where patients often experience compromised immune systems.

The competitive landscape is influenced by factors such as innovation in probiotic formulations, strategic partnerships, and a focus on delivering evidence-based products to healthcare providers. Companies are striving to differentiate themselves through high-quality, efficacious probiotic strains that meet the specific needs of patients in sensitive environments.

Kerry Group has positioned itself robustly within the Hospital and Nursing Home Probiotic Market through a sustained commitment to research and product development. The company focuses on leveraging its extensive expertise in the food and nutrition sectors to develop tailored probiotic solutions that cater to the unique dietary requirements of patients in healthcare settings. With a strong emphasis on quality and efficacy, Kerry Group has developed a range of probiotic offerings that are not only functional but also compatible with specific dietary needs such as lactose intolerance or low-sugar requirements.

The company’s advanced manufacturing capabilities and dedication to safety ensure that their probiotic products can be trusted by healthcare professionals in the hospital and nursing home context. Furthermore, Kerry Group's collaboration with research institutions reinforces its reputation as a leader in the development of scientifically-backed probiotic solutions.

Chr. Hansen is another prominent player in the Hospital and Nursing Home Probiotic Market, known for its commitment to innovation and sustainability. The company specializes in developing high-quality probiotics with proven benefits for gut health, immunity, and overall wellness. Chr. Hansen's strong emphasis on research and development allows it to stay at the forefront of probiotic science, continually advancing its product offerings to meet the evolving needs of healthcare providers. Their products are extensively tested for efficacy and safety, making them highly regarded among healthcare professionals. Chr.

Hansen also prioritizes strong customer relationships, ensuring that its probiotic solutions are designed with input from healthcare practitioners. This collaborative approach not only strengthens their product acceptance in hospitals and nursing homes but also reinforces Chr. Hansen’s position as a trusted partner in healthcare innovation. Through their sustainability initiatives, the company aligns itself with modern healthcare values, which is increasingly important for institutions aiming to improve patient care while also being environmentally responsible.

### **Key Companies in the Hospital and Nursing Home Probiotic Market Include**

**Hospital and Nursing Home Probiotic Market Industry Developments**

Recent developments in the Hospital and Nursing Home Probiotic Market indicate a notable increase in demand for probiotic supplements in healthcare settings, driven by an increased focus on gut health and infection prevention. Companies like Synlogic and DuPont have been actively launching new probiotic formulations tailored for clinical applications, catering to the growing interest from healthcare providers. Current affairs highlight the ongoing collaboration between biotech firms and hospitals to study the efficacy of probiotics in improving patient outcomes, particularly concerning antibiotic-associated complications.

Additionally, significant mergers and acquisitions have been observed, such as the acquisition of ProbioFerm by the health and wellness company Bifodan, which bolsters their product offerings and market position. The valuation of companies within the sector, including Thrive Probiotic and BioCare Copenhagen, is witnessing substantial growth, which is projected to contribute positively to the overall market growth. This investment influx is enhancing research capabilities and product development, thereby expanding the market's potential to meet increasing healthcare demands.

## **Hospital And Nursing Home Probiotic Market Segmentation Insights**

### **Hospital and Nursing Home Probiotic Market Probiotic Formulation Type Outlook**

- 

### **Hospital and Nursing Home Probiotic Market Target Patient Group Outlook**

- 

### **Hospital and Nursing Home Probiotic Market Indication Outlook**

- 

### **Hospital and Nursing Home Probiotic Market Distribution Channel Outlook**

- 

### **Hospital and Nursing Home Probiotic Market Product Source Outlook**

- 

### **Hospital and Nursing Home Probiotic Market Regional Outlook**

- - North America - Europe - South America - Asia Pacific

## Market Drivers

### 日益关注预防性医疗

向预防性医疗的转变正在影响医院和护理院益生菌市场。随着全球医疗系统强调预防而非治疗，益生菌因其在维持肠道健康和预防感染方面的作用而受到认可。数据显示，益生菌可以减少抗生素相关腹泻的发生率，这在医院环境中是一个常见问题。这种预防性方法不仅增强了患者护理，还与减少医院再入院的更广泛医疗趋势相一致。因此，医院和护理院越来越多地将益生菌干预作为其预防策略的一部分，这可能导致市场需求的持续增长。

### 益生菌产品的监管支持

监管机构越来越认识到益生菌的好处，这对医院和护理院益生菌市场产生了积极影响。最近的益生菌配方指南和批准鼓励医疗服务提供者将这些产品纳入他们的治疗方案中。这种监管支持不仅增强了益生菌的可信度，还促进了它们在临床实践中的整合。随着医院和护理院寻求基于证据的解决方案以改善患者护理，临床验证的益生菌产品的可用性可能会推动市场扩展。此外，持续的研究和开发努力可能会导致新益生菌菌株的引入，进一步丰富市场格局。

### 消化系统疾病发病率增加

消化系统疾病的日益普遍，例如肠易激综合症和炎症性肠病，似乎是医院和护理院益生菌市场的重要驱动因素。根据最近的数据，近15%的人口经历某种形式的消化问题，导致对益生菌解决方案的需求增加。医院和护理院越来越多地将益生菌纳入其治疗方案，以增强肠道健康并改善患者的治疗效果。随着医疗服务提供者认识到益生菌在管理消化系统疾病方面的潜在好处，这一趋势可能会持续下去。此外，益生菌在临床环境中的整合可能会提高患者满意度并降低医疗成本，从而进一步加强市场的增长轨迹。

### 功能性食品和补充剂需求上升

消费者对功能性食品和膳食补充剂的日益关注正在影响医院和护理院的益生菌市场。患者和医疗服务提供者对益生菌相关的健康益处的认识不断提高，导致对富含益生菌的食品和补充剂的需求激增。这一趋势在医院和护理院环境中尤为明显，因为营养在患者康复中发挥着至关重要的作用。益生菌正被纳入餐单和饮食建议中，反映出向整体健康方法的更广泛转变。随着功能性食品市场的持续增长，医院和护理院可能会扩大其益生菌产品的供应，从而促进整体市场的增长。

### 老龄化人口与日益增加的医疗需求

老龄化人口是推动医院和护理院益生菌市场的一个关键因素。随着人们年龄的增长，他们的肠道健康往往会下降，使他们更容易感染和消化系统疾病。研究表明，益生菌可以支持免疫功能并改善肠道微生物群的平衡，这对老年患者尤其有益。预计到2050年，全球65岁及以上人口将达到15亿，因此在医疗保健环境中对益生菌的需求预计将上升。医院和护理院可能会扩大其益生菌产品，以满足这一人群的需求，从而推动市场增长。

## Future Outlook

医院和护理院益生菌市场预计将在2024年至2035年间以8.52%的年均增长率增长，推动因素包括对肠道健康的认识提高和医疗支出增加。

**New opportunities:**

- 为特定患者群体开发定制的益生菌配方。

到2035年，市场预计将强劲，反映出显著的增长和创新。

## Segment Insights

### 按益生菌配方类型：胶囊（最大）与粉末（增长最快）

医院和护理院益生菌市场揭示了多种配方类型，其中胶囊占据了最大的市场份额。这种形式因其便利性和易于消费而受到高度青睐，尤其是在可能对更复杂形式感到困难的老年患者中。紧随胶囊之后，粉末在需要可定制剂量和灵活性的环境中获得了显著的关注。液体形式和益生菌酸奶也对市场动态产生了影响，迎合了不同患者的偏好和饮食需求。

最近的趋势表明，粉末配方正经历显著的转变，成为增长最快的细分市场。将这些益生菌融入奶昔和其他食品中的能力使其对旨在改善患者营养的医院和护理院特别具有吸引力。此外，关于肠道健康的日益关注正在推动对创新形式的需求，进一步增强了所有配方类型的增长潜力。

胶囊（主导）与粉末（新兴）

胶囊是医院和护理院益生菌市场的主导形式，主要由于其存储方便和剂量准确。这种形式最小化了污染风险，并允许较长的保质期，这对医疗环境至关重要。相比之下，粉末益生菌迅速成为护理人员的首选，因为其多功能性。将粉末混合到食物或饮料中，使其对可能吞咽药丸有困难的患者更为实用。此外，粉末形式支持更大的定制性，使医疗专业人员能够根据个人健康需求调整益生菌摄入，从而推动其市场渗透。

### 按目标患者群体：婴儿（最大）与老年人（增长最快）

在医院和养老院益生菌市场中，婴儿细分市场占据了显著地位，反映出由于对益生菌在早期发展中的益处的日益关注，市场份额最高。医疗服务提供者和关注婴儿肠道健康的父母特别针对这一人群，导致了稳定的需求。

相反，老年细分市场正在迅速崛起，受到肠胃疾病日益普遍和老年人对健康管理意识增强的推动。随着他们寻求改善消化健康和整体福祉的解决方案，这一群体的益生菌消费显著增加，显示出市场焦点向老年消费者的转变。

婴儿：主导 vs. 老年人：新兴

婴儿细分市场的特点是强烈强调开发专门满足新生儿和幼儿需求的解决方案。这个人群需要高质量、安全且有效的益生菌产品，以促进健康的肠道菌群并支持免疫功能，从小开始。相比之下，老年细分市场则表现出越来越倾向于解决与衰老相关的消化健康问题的益生菌，例如便秘和肠道失调。两个细分市场展示了不同的市场特征；婴儿市场以已建立的需求为主导，而老年消费者则代表了一个新兴市场，受到健康意识提升和创新益生菌配方的推动，以应对他们独特的健康挑战。

### 按适应症：艰难梭状芽胞杆菌感染（最大）与肠易激综合症（增长最快）

在医院和护理院益生菌市场中，适应症细分市场的反应各不相同。艰难梭状芽胞杆菌感染占据了最大的市场份额，这主要是由于抗生素相关的肠道健康紊乱事件的增加。随后，肠易激综合症作为增长最快的细分市场，因患者对胃肠道疾病寻求缓解的意识和诊断率的提高而获得了关注。

艰难梭状芽胞杆菌感染（主导）与肠易激综合症（新兴）

艰难梭状芽胞杆菌感染（Clostridium difficile Infection）部分至关重要，因住院患者的复发性感染对医疗机构造成了显著负担。针对这一指征的益生菌被用于恢复肠道微生物群，显著降低复发率。相比之下，肠易激综合症（Irritable Bowel Syndrome）部分正在崛起，吸引了越来越多寻求预防健康措施的人群。随着医疗提供者强调肠道健康管理，这一部分迅速获得关注，研究表明益生菌与症状缓解之间存在关联，使其成为益生菌配方未来发展的关键焦点。

### 按分销渠道：医院（最大）与在线零售（增长最快）

在医院和护理院益生菌市场中，分销渠道在市场渗透和产品可用性方面发挥着关键作用。医院占据了市场的最大份额，这主要得益于它们将益生菌纳入患者护理方案的能力，以及对这些产品健康益处的日益认可。另一方面，护理院和药店等渠道也对分销格局做出了重要贡献，但在整体市场份额方面落后于医院。

医疗设施：医院（主导）与护理院（新兴）

医院在医疗环境中仍然是益生菌分发的主导力量。它们提供了一个结构化的环境来管理益生菌，确保满足特定患者的需求。相比之下，护理院代表了一个新兴领域，越来越认识到益生菌对老年居民整体健康和免疫健康的重要性。虽然医院受益于既定的协议和更大的网络，但护理院正经历着由对益生菌益处的高度认识驱动的增长，调整其护理模式以整合这些产品以获得更好的健康结果。

### 按产品来源：细菌菌株（最大）与合生元（增长最快）

在医院和护理院的益生菌市场中，细菌菌株部分占据了最大的市场份额，因为其已被证明的疗效和在各种治疗应用中的广泛使用。具体而言，像乳酸菌和双歧杆菌这样的菌株主导了这一类别，显著影响了医院和护理机构的消费者偏好。与此同时，酵母菌株和发酵食品部分紧随其后，但它们在市场份额中占据的比例较小，主要用于其独特的益生菌益处。总体而言，细菌菌株引领市场，反映了人们对其在临床环境中表现的长期信任。

细菌菌株（主导）与合成生物制剂（新兴）

细菌菌株仍然是医院和护理院益生菌市场的主导力量，以其强大的健康益处而受到认可，包括增强肠道健康和提升免疫系统。常见的医院使用菌株，如乳酸菌和双歧杆菌，因其治疗优势而得到充分记录，使其对医疗提供者而言易于识别。另一方面，合生元结合了益生元和益生菌，正在迅速崛起，因为医疗专业人员寻求全面的患者健康管理解决方案。它们支持肠道微生物群和整体健康的能力使其成为一个有吸引力的选择，满足了老龄化人群对创新益生菌应用日益增长的需求。

## Regional Market Share Analysis

### 北美：益生菌市场领导者

北美是医院和养老院益生菌的最大市场，约占全球市场份额的45%。增长的驱动因素包括对肠道健康的日益关注、医疗支出的增加以及支持性的监管框架。对医疗环境中益生菌的需求进一步受到老龄化人口和慢性疾病流行的推动，这些因素需要先进的营养解决方案。

美国在北美市场中处于领先地位，其次是加拿大。宝洁和达能等主要企业正在积极投资于研发，以创新益生菌配方。竞争格局以战略合作和收购为特征，增强了产品供应和市场覆盖。知名品牌的存在确保了强大的供应链和消费者信任，进一步巩固了北美在益生菌市场的地位。

### 欧洲：具有监管的新兴市场

欧洲在医院和养老院益生菌市场中正经历显著增长，约占全球市场份额的30%。需求的上升归因于健康意识的提高、老年人口的增长以及促进益生菌在医疗保健中使用的严格法规。欧洲食品安全局（EFSA）在建立确保产品安全和有效性的指南方面发挥了重要作用，从而增强了消费者信心。

该地区的主要国家包括德国、法国和英国，其中德国是最大的市场。达能和克里斯·汉森等主要企业专注于为医疗环境量身定制的创新益生菌解决方案。竞争格局以医疗提供者与益生菌制造商之间的合作为特征，增强了产品的可及性和意识。这种协同作用对推动市场增长和满足医疗设施不断变化的需求至关重要。

### 亚太地区：快速扩张的市场

亚太地区正迅速崛起为医院和养老院益生菌市场的重要参与者，约占全球市场份额的20%。增长的驱动因素包括医疗投资的增加、对肠道健康的日益关注以及老年人口的增长。中国和印度等国的益生菌需求激增，得益于政府倡导的健康和保健倡议。

中国是该地区最大的市场，其次是日本和印度。竞争格局中既有本地企业也有国际企业，雀巢和凯利集团等公司处于领先地位。市场的特点是提供多样化的益生菌产品，以满足医疗设施的特定需求。这种动态环境促进了创新，增强了医院和养老院中益生菌的可用性，以满足对有效健康解决方案日益增长的需求。

### 中东和非洲：医疗保健中的新兴机会

中东和非洲地区在医院和养老院益生菌市场中逐渐崭露头角，约占全球市场份额的5%。增长的驱动因素包括医疗投资的增加、对肠道健康的日益关注以及老年人口的增长。各国政府开始认识到益生菌在医疗保健中的重要性，出台支持性政策以鼓励其在医院和养老院中的使用。

南非和阿联酋等国在这一增长中处于前沿，医疗环境中对益生菌产品的需求不断增加。竞争格局正在演变，本地和国际企业纷纷进入市场。各公司专注于教育医疗专业人员关于益生菌的好处，这对推动医院和养老院的采用至关重要。这个新兴市场为益生菌行业的增长和创新提供了重要机会。

## Competitive Benchmarking

医院和护理院益生菌市场的特点是一个动态的格局，众多参与者竞争以在这个小众但不断增长的领域中建立自己的存在。随着医疗机构越来越认识到益生菌在改善患者结果方面的重要性，市场对益生菌的兴趣和投资激增。益生菌以其在支持肠道健康方面的重要作用而闻名，这在医院和护理院环境中尤为关键，因为患者常常面临免疫系统受损的问题。

竞争格局受到益生菌配方创新、战略合作伙伴关系以及专注于向医疗提供者提供循证产品等因素的影响。公司们努力通过高质量、有效的益生菌菌株来区分自己，以满足敏感环境中患者的特定需求。

Kerry Group通过持续致力于研究和产品开发，在医院和护理院益生菌市场中稳固了自己的地位。该公司专注于利用其在食品和营养领域的广泛专业知识，开发满足医疗环境中患者独特饮食需求的定制益生菌解决方案。Kerry Group强调质量和有效性，开发了一系列不仅功能性强，而且兼容特定饮食需求（如乳糖不耐受或低糖要求）的益生菌产品。

该公司的先进制造能力和对安全性的承诺确保其益生菌产品可以被医院和护理院的医疗专业人员信赖。此外，Kerry Group与研究机构的合作进一步巩固了其作为科学支持的益生菌解决方案开发领导者的声誉。

Chr. Hansen是医院和护理院益生菌市场的另一个重要参与者，以其对创新和可持续发展的承诺而闻名。该公司专注于开发具有肠道健康、免疫力和整体健康益处的高质量益生菌。Chr. Hansen对研究和开发的强烈重视使其能够始终处于益生菌科学的前沿，不断推进其产品以满足医疗提供者不断变化的需求。他们的产品经过广泛的有效性和安全性测试，在医疗专业人员中享有很高的声誉。Chr.

Hansen还优先考虑与客户建立良好的关系，确保其益生菌解决方案在设计时考虑到医疗从业者的意见。这种协作方法不仅增强了他们在医院和护理院的产品接受度，还巩固了Chr. Hansen作为医疗创新可信合作伙伴的地位。通过其可持续发展倡议，该公司与现代医疗价值观保持一致，这对旨在改善患者护理同时又对环境负责的机构来说越来越重要。

## Recent News & Developments

医院和护理院益生菌市场的最新发展表明，医疗环境中对益生菌补充剂的需求显著增加，这一趋势受到对肠道健康和感染预防的关注增加的推动。像Synlogic和杜邦这样的公司积极推出针对临床应用的新益生菌配方，以满足医疗提供者日益增长的兴趣。时事新闻突显了生物技术公司与医院之间的持续合作，以研究益生菌在改善患者结果方面的有效性，特别是与抗生素相关的并发症。

此外，观察到显著的并购活动，例如健康与保健公司Bifodan收购ProbioFerm，这增强了他们的产品供应和市场地位。包括Thrive Probiotic和BioCare Copenhagen在内的行业内公司的估值正在经历显著增长，预计将对整体市场增长产生积极贡献。这一投资涌入正在增强研究能力和产品开发，从而扩大市场满足日益增长的医疗需求的潜力。

## Report Scope

| 2024年市场规模 | 2.939（十亿美元） |
| --- | --- |
| 2025年市场规模 | 3.19（十亿美元） |
| 2035年市场规模 | 7.226（十亿美元） |
| 复合年增长率（CAGR） | 8.52%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 关键公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 关键市场机会 | 整合先进的益生菌配方以增强患者恢复和肠道健康在医疗环境中的应用。 |
| 关键市场动态 | 医疗环境中对益生菌需求的上升推动了医院和养老院益生菌市场的创新和监管审查。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 到2035年，医院和护理院益生菌市场的预计市场估值是多少？**
A: 预计到2035年，医院和护理院益生菌市场的市场估值为72.26亿美元。

**Q: 2024年医院和护理院益生菌市场的市场估值是多少？**
A: 2024年医院和护理院益生菌市场的整体市场估值为29.39亿美元。

**Q: 2025年至2035年，医院和护理院益生菌市场的预期CAGR是多少？**
A: 医院和护理院益生菌市场在2025年至2035年预测期内的预期CAGR为8.52%。

**Q: 在医院和护理院益生菌市场中，哪些公司被视为关键参与者？**
A: 市场的主要参与者包括达能、雀巢、宝洁、凯利集团、克里斯·汉森、拉克塔利斯成分、Synlogic、BioCare Copenhagen 和 ProbioFerm。

**Q: 2025年益生菌胶囊的预计收入是多少？**
A: 预计益生菌胶囊将在2025年产生19.78亿美元的收入。

**Q: 2025年，益生菌粉的收入与益生菌液体的收入相比如何？**
A: 到2025年，益生菌粉预计将产生13.68亿美元的收入，这与益生菌液体的预计收入相等。

**Q: 2025年针对老年患者的益生菌预期收入是多少？**
A: 针对老年患者的益生菌预计将在2025年产生15亿美元的收入。

**Q: 预计哪个分销渠道在2025年将产生最高收入？**
A: 预计到2025年，医院将产生最高的收入，预计为19.78亿美元。

**Q: 2025年益生菌酸奶的预期收入是多少？**
A: 预计益生菌酸奶将在2025年产生12.26亿美元的收入。

**Q: 2025年针对胃肠道疾病患者的益生菌产品预计收入是多少？**
A: 针对胃肠道疾病患者的益生菌产品预计将在2025年产生15.26亿美元的收入。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/hospital-and-nursing-home-probiotic-market-31965*